ArticleInternational journal of medical sciences2026
Cytotoxic Effects of the Synthetic Cannabinoid, 5F-MDMB-PICA on Human Glioblastoma U87-MG Cells.
Article in International journal of medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Synthetic cannabinoids, particularly 5F-MDMB-PICA, have emerged as potent psychoactive substances, exhibiting a binding affinity to the CB1 receptor approximately 380 times greater than that of Δ9-THC, the principal psychoactive compound in cannabis. Their widespread abuse has been associated with severe intoxication and fatalities globally. This study aimed to investigate the cytotoxic effects and mechanisms of 5F-MDMB-PICA in U87-MG astrocyte-like cells, a common model in neurobiological research. U87-MG cells (passages 7-15) were treated with increasing concentrations of 5F-MDMB-PICA (1-200 μM) for 24 hours. We employed several assays to evaluate cytotoxicity (MTT assay), oxidative stress, mitochondrial membrane potential, cellular migration (wound healing), and cell death (flow cytometry). Additionally, gene expression analysis via qRT-PCR focused on apoptotic and inflammatory markers. A receptor docking study was performed to verify similarities in binding sites between 5F-MDMB-PICA and Δ9-THC. Our results showed that exposure to 5F-MDMB-PICA led to a concentration-dependent increase in cytotoxicity and oxidative stress, alongside a significant decrease in mitochondrial membrane potential. There was a marked elevation in apoptosis and necrosis, coupled with impaired cellular migration. Gene expression analysis revealed significant upregulation of pro-apoptotic and inflammatory genes, such as P53, Bax, TNF-α, and COX-2, indicating a robust pro-apoptotic and pro-inflammatory response. Notably, key residues (Phe200 and Ser383) in the CB1 binding pocket were identified as crucial for the interaction of both compounds, which might provide insight into the shared patterns of cytotoxic effects. These findings highlight the neurotoxic effects of 5F-MDMB-PICA, underscoring the serious public health risks associated with synthetic cannabinoids.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.